carnitine has been researched along with Dry Eye in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To prepare the levocarnitine thermosensitive in situ gel (LCTG) and evaluate its effect on dry eye disease (DED)." | 8.02 | Topical Delivery of Levocarnitine to the Cornea and Anterior Eye by Thermosensitive in-situ Gel for Dry Eye Disease. ( Bai, J; Cai, M; Huang, P; Ma, B; Ni, J; Pang, L; Qu, C; Wu, H; Xu, Y; Yang, J; Yin, X; Zhang, Z, 2021) |
| "The dry eye disease was defined as a multifactorial drop disease concerning tears and ocular surface, which brings to discomfort symptoms and visual disorders with potential damage to the ocular surface." | 6.78 | Iatrogenic dry eye disease: an eledoisin/carnitine and osmolyte drops study. ( Evangelista, M; Librando, A; Nebbioso, M; Pescosolido, N; Plateroti, AM, 2013) |
| "Carnitine levels were assessed by high performance liquid chromatography-mass spectrometry." | 5.35 | L-carnitine and short chain ester in tears from patients with dry eye. ( Imperatrice, B; Koverech, A; Messano, M; Pescosolido, N, 2009) |
| "To prepare the levocarnitine thermosensitive in situ gel (LCTG) and evaluate its effect on dry eye disease (DED)." | 4.02 | Topical Delivery of Levocarnitine to the Cornea and Anterior Eye by Thermosensitive in-situ Gel for Dry Eye Disease. ( Bai, J; Cai, M; Huang, P; Ma, B; Ni, J; Pang, L; Qu, C; Wu, H; Xu, Y; Yang, J; Yin, X; Zhang, Z, 2021) |
| "Topical application of betaine, L-carnitine, or erythritol systematically limited progression of environmentally induced dry eye." | 3.79 | Efficacy of osmoprotectants on prevention and treatment of murine dry eye. ( Chen, Q; Chen, W; Garrett, Q; Hou, C; Li, J; Wang, Y; Zhang, X, 2013) |
| "The dry eye disease was defined as a multifactorial drop disease concerning tears and ocular surface, which brings to discomfort symptoms and visual disorders with potential damage to the ocular surface." | 2.78 | Iatrogenic dry eye disease: an eledoisin/carnitine and osmolyte drops study. ( Evangelista, M; Librando, A; Nebbioso, M; Pescosolido, N; Plateroti, AM, 2013) |
| "Carnitine levels were assessed by high performance liquid chromatography-mass spectrometry." | 1.35 | L-carnitine and short chain ester in tears from patients with dry eye. ( Imperatrice, B; Koverech, A; Messano, M; Pescosolido, N, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rossi, GCM | 1 |
| Scudeller, L | 1 |
| Bettio, F | 1 |
| Milano, G | 1 |
| Ma, B | 1 |
| Pang, L | 1 |
| Huang, P | 1 |
| Bai, J | 1 |
| Zhang, Z | 1 |
| Wu, H | 1 |
| Cai, M | 1 |
| Yang, J | 1 |
| Xu, Y | 1 |
| Yin, X | 1 |
| Qu, C | 1 |
| Ni, J | 1 |
| López-Cano, JJ | 1 |
| González-Cela-Casamayor, MA | 1 |
| Andrés-Guerrero, V | 1 |
| Herrero-Vanrell, R | 1 |
| Benítez-Del-Castillo, JM | 1 |
| Molina-Martínez, IT | 1 |
| Nebbioso, M | 1 |
| Evangelista, M | 1 |
| Librando, A | 1 |
| Plateroti, AM | 1 |
| Pescosolido, N | 2 |
| Chen, W | 1 |
| Zhang, X | 1 |
| Li, J | 1 |
| Wang, Y | 1 |
| Chen, Q | 1 |
| Hou, C | 1 |
| Garrett, Q | 1 |
| Imperatrice, B | 1 |
| Koverech, A | 1 |
| Messano, M | 1 |
2 trials available for carnitine and Dry Eye
| Article | Year |
|---|---|
A Pilot, Phase II, Observational, Case-Control, 1-Month Study on Asthenopia in Video Terminal Operators without Dry Eye: Contrast Sensitivity and Quality of Life before and after the Oral Consumption of a Fixed Combination of Zinc, L-Carnitine, Extract of
Topics: Administration, Oral; Adult; Asthenopia; Carnitine; Computer Terminals; Dry Eye Syndromes; Eleuthero | 2021 |
Iatrogenic dry eye disease: an eledoisin/carnitine and osmolyte drops study.
Topics: Aged; Aged, 80 and over; Carnitine; Double-Blind Method; Dry Eye Syndromes; Eledoisin; Female; Human | 2013 |
4 other studies available for carnitine and Dry Eye
| Article | Year |
|---|---|
Topical Delivery of Levocarnitine to the Cornea and Anterior Eye by Thermosensitive in-situ Gel for Dry Eye Disease.
Topics: Administration, Ophthalmic; Animals; Carnitine; Cornea; Disease Models, Animal; Drug Delivery System | 2021 |
Combined hyperosmolarity and inflammatory conditions in stressed human corneal epithelial cells and macrophages to evaluate osmoprotective agents as potential DED treatments.
Topics: Animals; Apoptosis; Betaine; Carnitine; Cell Survival; Cells, Cultured; Dry Eye Syndromes; Epitheliu | 2021 |
Efficacy of osmoprotectants on prevention and treatment of murine dry eye.
Topics: Animals; Apoptosis; Betaine; Carnitine; Cornea; Disease Models, Animal; Disease Progression; Dry Eye | 2013 |
L-carnitine and short chain ester in tears from patients with dry eye.
Topics: Aged; Carnitine; Chromatography, High Pressure Liquid; Dry Eye Syndromes; Female; Follow-Up Studies; | 2009 |